The text has been copied to the clipboard
Journal article

Sphingolipid composition of circulating extracellular vesicles after myocardial ischemia.

  • Burrello J Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, Via Tesserete 48, 6900, Lugano, Switzerland.
  • Biemmi V Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, Via Tesserete 48, 6900, Lugano, Switzerland.
  • Dei Cas M Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
  • Amongero M Department of Mathematical Sciences G. L. Lagrange, Polytechnic University of Torino, Torino, Italy.
  • Bolis S Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, Via Tesserete 48, 6900, Lugano, Switzerland.
  • Lazzarini E Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, Via Tesserete 48, 6900, Lugano, Switzerland.
  • Bollini S Regenerative Medicine Laboratory, Dept. of Experimental Medicine (DIMES), University of Genova, Genova, Italy.
  • Vassalli G Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
  • Paroni R Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
  • Barile L Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, Via Tesserete 48, 6900, Lugano, Switzerland. lucio.barile@cardiocentro.org.
Show more…
  • 2020-10-01
Published in:
  • Scientific reports. - 2020
English Sphingolipids are structural components of cell membrane, displaying several functions in cell signalling. Extracellular vesicles (EV) are lipid bilayer membrane nanoparticle and their lipid composition may be different from parental cells, with a significant enrichment in sphingolipid species, especially in pathological conditions. We aimed at optimizing EV isolation from plasma and describing the differential lipid content of EV, as compared to whole plasma. As pilot study, we evaluated the diagnostic potential of lipidomic signature of circulating EV in patients with a diagnosis of ST-segment-elevation myocardial infarction (STEMI). STEMI patients were evaluated before reperfusion and 24-h after primary percutaneous coronary intervention. Twenty sphingolipid species were quantified by liquid-chromatography tandem-mass-spectrometry. EV-ceramides, -dihydroceramides, and -sphingomyelins increased in STEMI vs. matched controls and decreased after reperfusion. Their levels correlated to hs-troponin, leucocyte count, and ejection fraction. Plasma sphingolipids levels were 500-to-700-fold higher as compared to EV content; nevertheless, only sphingomyelins differed in STEMI vs. control patients. Different sphingolipid species were enriched in EV and their linear combination by machine learning algorithms accurately classified STEMI patients at pre-PCI evaluation. In conclusion, EV lipid signature discriminates STEMI patients. These findings may contribute to the identification of novel biomarkers and signaling mechanisms related to cardiac ischemia.
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://sonar.ch/global/documents/279135
Export to…

Statistics

Document views: 71 File downloads:
  • Full-text: 0